Concepedia

Sander Busker

SB

Statistics

Publications

7

Citations

267

H-Index

7

Active since

2017

Affiliations

Karolinska Institutet(Current)

Science for Life Laboratory

University of British Columbia

National Institute of Oncology

Justus-Liebig-Universität Gießen

Sander Busker is an author at Karolinska Institutet specializing in life sciences, stat3 signaling, and molecular biology.

ORCID

Publications per year

2017–2022

7

Publications

7

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death

Sander Busker, Martin Haraldsson, Belén Espinosa et al. · Science Advances · 2020 · 74 citations · Full text

, , +4

Selective, Modular Probes for Thioredoxins Enabled by Rational Tuning of a Unique Disulfide Structure Motif

Jan G. Felber, Lukas Zeisel, Lena Poczka et al. · Journal of the American Chemical Society · 2021 · 54 citations

, , +17

Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically

Jan G. Felber, Lena Poczka, Karoline Scholzen et al. · Nature Communications · 2022 · 44 citations · Full text

, , +15

To inhibit TrxR1 is to inactivate STAT3–Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors

Sander Busker, Brent D. G. Page, Elias S.J. Arnér · Redox Biology · 2020 · 33 citations · Full text

, , +9

Identification of novel small molecules that inhibit STAT3-dependent transcription and function

Iryna Kolosenko, Yasmin Yu, Sander Busker et al. · PLoS ONE · 2017 · 23 citations · Full text

, , +14

1–5 of 7